14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CRBP
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Big movements in Corbus Pharmaceuticals Holdings stock price on Wednesday moving 11.97% between high and low
(Updated on Apr 24, 2024)

Sell candidate since Apr 22, 2024 Loss -5.73% PDF

The Corbus Pharmaceuticals Holdings stock price fell by -5.83% on the last day (Wednesday, 24th Apr 2024) from $37.74 to $35.54. During the last trading day the stock fluctuated 11.97% from a day low at $34.24 to a day high of $38.34. The price has been going up and down for this period, and there has been a -6.84% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -281 thousand shares and in total, 220 thousand shares were bought and sold for approximately $7.82 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 58.98% during the next 3 months and, with a 90% probability hold a price between $47.02 and $90.56 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CRBP Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Corbus Pharmaceuticals Holdings stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $37.86 and $39.37. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, March 13, 2024, and so far it has fallen -24.51%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Corbus Pharmaceuticals Holdings stock

On the downside, the stock finds support just below today's level from accumulated volume at $29.49 and $27.79. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Corbus Pharmaceuticals Holdings finds support just below today's level at $29.49. If this is broken, then the next support from accumulated volume will be at $27.79 and $27.15.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $4.10 between high and low, or 11.97%. For the last week, the stock has had daily average volatility of 9.07%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CRBP) For The Upcoming Trading Day Of Thursday 25th

For the upcoming trading day on Thursday, 25th we expect Corbus Pharmaceuticals Holdings to open at $36.04, and during the day (based on 14 day Average True Range), to move between $31.85 and $39.23, which gives a possible trading interval of +/-$3.69 (+/-10.37%) up or down from last closing price. If Corbus Pharmaceuticals Holdings takes out the full calculated possible swing range there will be an estimated 20.75% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $37.74 (6.19%) than the support at $29.49 (17.02%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Corbus Pharmaceuticals Holdings stock A Buy?

The Corbus Pharmaceuticals Holdings stock holds several negative signals and despite the positive trend, we believe Corbus Pharmaceuticals Holdings will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -1.296 Sell Candidate Unchanged

Predicted Opening Price for Corbus Pharmaceuticals Holdings of Thursday, April 25, 2024

Fair opening price April 25, 2024 Current price
$36.04 ( 1.41%) $35.54

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CRBP

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 40.14 12.94 %
R2 38.57 8.54 %
R1 37.61 5.81 %
Current price: 35.54
Support S1 34.47 -3.00 %
S2 33.51 -5.72 %
S3 31.94 -10.13 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 40.32 13.45 %
R2 39.24 10.41 %
R1 37.74 6.19 %
Current price 35.54
Support S1 29.49 -17.02%
S2 27.79 -21.81%
S3 27.15 -23.61%

FAQ

What is the symbol for Corbus Pharmaceuticals Holdings Stock and on which exchange is it traded?
The symbol for Corbus Pharmaceuticals Holdings is CRBP and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Corbus Pharmaceuticals Holdings Stock?
The Corbus Pharmaceuticals Holdings stock holds several negative signals and despite the positive trend, we believe Corbus Pharmaceuticals Holdings will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Corbus Pharmaceuticals Holdings Stock?
Corbus Pharmaceuticals Holdings Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Corbus Pharmaceuticals Holdings Stock.

What's the current price of Corbus Pharmaceuticals Holdings Stock?
As of the end of day on the Apr 24, 2024, the price of an Corbus Pharmaceuticals Holdings (CRBP) share was $35.54.

What is the 52-week high and low for Corbus Pharmaceuticals Holdings Stock?
The 52-week high for Corbus Pharmaceuticals Holdings Stock is $49.87 and the 52-week low is $3.03.

What is the market capitalization of Corbus Pharmaceuticals Holdings Stock?
As of the Apr 24, 2024, the market capitalization of Corbus Pharmaceuticals Holdings is 372.925M.

When is the next earnings date for Corbus Pharmaceuticals Holdings?
The upcoming earnings date for Corbus Pharmaceuticals Holdings is May 14, 2024.
Click to get the best stock tips daily for free!

About Corbus Pharmaceuticals Holdings

Corbus Pharmaceuticals Holdings Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an anti-integrin monoclonal antibody (mAb) for the treatment of cancer and fibrosis that inhibits the act... CRBP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT